Silo Pharma, Inc. (SILO) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -822.62K | -780.28K | -955.49K | -1.29M | -1.64M | -917.43K | -1.35M | -731.8K | -838.18K | -910.01K | -1.07M | -549.97K |
| Operating CF Margin % | -4563.54% | -4328.63% | -5300.93% | -7130.47% | -9099.63% | -5089.49% | -7470.18% | -4059.93% | -4649.83% | -5048.33% | -5946.36% | -3051.13% |
| Operating CF Growth % | 49.85% | 14.95% | 29.04% | -75.63% | -95.7% | -0.82% | -25.63% | -33.06% | -21% | -2.71% | 24.64% | -37.45% |
| Net Income | -1.65M | -881.53K | -1.11M | 1.03M | -1.03M | -1.73M | -928.81K | -931.78K | -801.67K | -1.12M | -660.16K | -1.01M |
| Depreciation & Amortization | 2.94K | 2.94K | 2.94K | -3.09K | 3.09K | 3.09K | 3.09K | 0 | 0 | 56.29K | 0 | 0 |
| Stock-Based Compensation | 0 | 52.31K | 47.27K | 0 | 0 | 0 | 0 | 0 | 0 | 1.41K | 26.75K | 4.24K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 882.46K | 104.87K | 520.91K | -2.21M | -2.92K | 0 | 0 | 1.26K | -234 | 9.27K | 1.86K | 39.46K |
| Working Capital Changes | -60.9K | -58.86K | -416.18K | -99.9K | -609.03K | 810.1K | -420.78K | 198.72K | -36.28K | 144.19K | -440.29K | 419.29K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.59K | -1.21K | -1.2K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.59K | 1.21K | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 98.08K | 96.82K | -441.42K | 387.81K |
| Cash from Investing | -23.56K | -519.99K | -95.47K | 388.1K | 871.38K | -37.66K | -40.43K | 954.27K | 97.6K | 4.43M | 1.26M | -3.83M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | 0.02% | - | 0.02% | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -499.95K | 0 | 1.26M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 2.13M | 634.92K | 2.09M | 0 | 0 | 1.74M | 1.62M | -115.45K | -194.42K | -145.74K | -130.96K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 2.13M | 634.92K | 2.09M | 0 | 0 | 1.74M | 1.62M | -115.45K | -194.42K | -145.74K | -130.96K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -57.66K | -115.45K | -194.42K | -145.74K | -130.96K |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -846.19K | 831.07K | -416.05K | 1.2M | -768.92K | -955.09K | 354.59K | 1.84M | -856.03K | 3.32M | 41.01K | -4.51M |
| Free Cash Flow | -822.62K | -780.28K | -955.49K | -1.29M | -1.64M | -917.43K | -1.35M | -731.8K | -838.18K | -910.01K | -1.07M | -549.97K |
| FCF Margin % | -4563.52% | -4328.63% | -5300.92% | -7130.47% | -9099.63% | -5089.49% | -7470.18% | -4059.93% | -4649.83% | -5048.33% | -5946.36% | -3051.13% |
| FCF Growth % | 49.85% | 14.95% | 29.04% | -75.63% | -95.7% | -0.82% | -25.63% | -33.06% | -21% | -2.71% | 24.64% | -37.45% |
| FCF per Share | -0.90 | -0.88 | -1.54 | -3.07 | -5.49 | -3.07 | -4.70 | -3.60 | -4.39 | -4.70 | -5.17 | -2.62 |
| FCF Conversion (FCF/Net Income) | 0.50x | 0.89x | 0.86x | 1.07x | 1.59x | 0.53x | 1.45x | 0.79x | 1.05x | 0.81x | 1.62x | 0.54x |
| Interest Paid | 0 | 0 | 0 | 0 | 2.07K | 274 | 1.08K | 1.86K | 0 | 0 | 0 | -164.17K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |